灌流装置の世界市場予測(~2021年)...市場調査レポートについてご紹介

【英文タイトル】Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Perfusion Systems: Market Overview
4.2 Geographic Analysis: Perfusion Systems Market, By Type (2016)
4.3 Cell Perfusion Systems Market, By Type, 2016 vs 2021
4.4 Geographic Snapshot of the Market

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
5.2.1.2 Rising Number of Organ Transplantations
5.2.1.2.1 Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
5.2.1.2.2 Government and NGO Initiatives to Encourage Organ Donation
5.2.1.3 Increasing Investments in Cell-Based Research
5.2.1.4 Increase in Biologic Manufacturing
5.2.2 Restraints
5.2.2.1 High Cost of Organ Transplantation
5.2.2.2 Ethical Concerns and High Cost of Cell-Based Research
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Research in Emerging Markets
5.2.3.2 Rising Preference for Continuous Manufacturing
5.2.4 Challenge
5.2.4.1 Organ Supply-Demand Gap

6 Cardiopulmonary Perfusion Systems Market, By Component (Page No. – 43)
6.1 Introduction
6.2 Oxygenators
6.3 Heart-Lung Machines
6.4 Perfusion Pumps
6.5 Cannulas
6.6 Monitoring Systems
6.7 Other Components
6.7.1 Arterial Filters
6.7.2 Reservoirs
6.7.3 Data Management Systems
6.7.4 Cardioplegia Delivery Systems
6.7.5 Heat Exchangers
6.7.6 Accessories

7 Cell Perfusion Systems Market, By Type (Page No. – 49)
7.1 Introduction
7.2 Bioreactor Perfusion Systems
7.3 Microfluidic Perfusion Systems
7.4 Gravity Or Pressure-Driven Perfusion Systems
7.5 Small-Mammal Organ Perfusion Systems

8 EX Vivo Organ Perfusion Market, By Technique (Page No. – 53)
8.1 Introduction
8.2 Hypothermic Machine Perfusion
8.3 Normothermic Machine Perfusion

9 Global Perfusion Systems Market, By Region (Page No. – 57)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Rise in Cardiovascular Disease Prevalence
9.2.1.2 Technological Advancements in Organ Preservation
9.2.1.3 Increasing Organ Transplants
9.2.1.4 Introduction of the 21st Century Cures Act
9.2.1.5 Favorable Scenario for Cell Research, Growing Research Funding
9.2.1.6 Growth of the Pharmaceutical and Biotechnology Sector
9.2.2 Canada
9.2.2.1 Increasing Incidences of Heart Diseases
9.2.2.2 Favorable Reimbursement Scenario for Living Donors Within Some Provinces
9.2.2.3 Increasing Investment in Regenerative Medicine Research Projects
9.3 Europe
9.3.1 Rapidly Aging Population, High Prevalence of Cardiovascular Diseases in Europe
9.3.2 Europe-5
9.3.2.1 Changes in Organ Donation Laws in Wales
9.3.2.2 Strong Academic and Research Base in Germany
9.3.2.3 Funding for Research in the U.K.
9.3.2.4 Increasing Cancer Research in France
9.3.2.5 Italy: Growing Biotech Industry to Aid Market Growth
9.3.3 RoE
9.3.3.1 Strong Presence of Pharmaceutical and Biotechnology Companies
9.3.3.2 Increasing Research in Denmark and Sweden
9.4 Asia-Pacific
9.4.1 Increasing Aging Population, Rise in Cardiovascular Surgery
9.4.2 Japan
9.4.2.1 Rising Organ Donations and Transplants
9.4.2.2 Rise in Vaccine Production in Japan
9.4.2.3 Regenerative Medicine and Biomedical & Medical Research in Japan
9.4.3 China
9.4.3.1 Regulatory Framework for Voluntary Organ Donations
9.4.3.2 Increasing Government Interest in Biomedical and Biotechnology Industries
9.4.3.3 Growth of the Pharmaceutical and Biotechnology R&D Industry and Cros Sector
9.4.4 India
9.4.4.1 Religious Beliefs and Lack of Healthcare Infrastructure in India
9.4.4.2 Growing Pharmaceutical and Biotechnology Industry, Government Initiatives
9.4.5 Rest of Asia-Pacific
9.4.5.1 Taiwan: Increasing Government Support for Academic and Commercial R&D
9.4.5.2 Establishment of R&D Centers in Singapore
9.4.5.3 Korea-U.S. Free Trade Agreement (Korus)
9.5 Rest of the World
9.5.1 Campaigns to Encourage Organ Donation in Brazil
9.5.2 Flourishing Biotechnology and Pharmaceutical Markets in Brazil
9.5.3 Significant Developments in the Pharmaceutical Market in Africa
9.5.4 Favorable Regulatory Environment in Saudi Arabia, Iran, and Israel

10 Competitive Landscape (Page No. – 97)
10.1 Introduction
10.1.1 Vanguards
10.1.2 Innovator
10.1.3 Dynamic
10.1.4 Emerging
10.2 Competitive Benchmarking
10.2.1 Product Offerings
10.2.2 Business Strategy

*Top 13 Companies Analyzed for This Studies are – Getinge AB (Sweden), Medtronic PLC (Ireland), Terumo Corporation (Japan), Livanova PLC (U.K.), Xenios AG (Germany), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Nipro Corporation (Japan), Harvard Bioscience, Inc. (U.S.), ALA Scientific Instruments, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), and Xvivo Perfusion AB (Sweden).

11 Company Profile (Page No. – 101)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Getinge AB
11.2 Medtronic PLC
11.3 Livanova PLC
11.4 Terumo Corporation
11.5 Nipro Corporation
11.6 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
11.7 Repligen Corporation
11.8 Spectrum Laboratories, Inc.
11.9 Merck KGaA
11.10 Harvard Bioscience, Inc.
11.11 ALA Scientific Instruments, Inc.
11.12 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
11.13 Xvivo Perfusion AB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 144)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.3.1 Features and Benefits of RT
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (74 Tables)

Table 1 Biomanufacturing Projects Announced in 2015 and 2016
Table 2 Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 3 Oxygenators Market Size, By Region, 2014-2021 (USD Million)
Table 4 Heart-Lung Machines Market Size, By Region, 2014-2021 (USD Million)
Table 5 Perfusion Pumps Market Size, By Region, 2014-2021 (USD Million)
Table 6 Cannulas Market Size, By Region, 2014-2021 (USD Million)
Table 7 Monitoring Systems Market Size, By Region, 2014-2021 (USD Million)
Table 8 Other Components Market Size, By Region, 2014-2021 (USD Million)
Table 9 Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 10 Bioreactor Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 11 Microfluidic Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 12 Gravity Or Pressure-Driven Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 13 Small-Mammal Organ Perfusion Systems Market Size, By Region, 2014-2021 (USD Million)
Table 14 EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 15 Advantages and Disadvantages of the HMP Technique
Table 16 Hypothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 17 Normothermic Machine Perfusion Market Size, By Region, 2014-2021 (USD Million)
Table 18 Global Market Size, By Region, 2014-2021 (USD Million)
Table 19 Global Market Size, By Type, 2014-2021 (USD Million)
Table 20 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 21 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 22 North America: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 23 North America: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 24 North America: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 25 Number of Organ Transplants in the U.S. (2014-2016)
Table 26 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 27 U.S.: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 28 U.S.: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 29 U.S.: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 30 Canada: Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 31 Canada: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 32 Canada: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 33 Canada: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 34 Europe: Market Size, By Region, 2014-2021 (USD Million)
Table 35 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 36 Europe: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 37 Europe: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 38 Europe: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 39 Europe-5: Market Size, By Type, 2014-2021 (USD Million)
Table 40 Europe-5: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 41 Europe-5: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 42 Europe-5: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 43 Indicative List: Companies Headquartered in RoE Countries
Table 44 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 45 RoE: Cardiopulmonary Market Size, By Component, 2014-2021 (USD Million)
Table 46 RoE: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 47 RoE: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 48 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 49 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 50 Asia-Pacific: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 51 Asia-Pacific: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 52 Asia-Pacific: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 53 Number of Organ Donations and Transplants in Japan (2013-2016)
Table 54 Japan: Market Size, By Type, 2014-2021 (USD Million)
Table 55 Japan: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 56 Japan: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 57 Japan: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 58 China: Market Size, By Type, 2014-2021 (USD Million)
Table 59 China: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 60 China: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 61 China: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 62 India: Market Size, By Type, 2014-2021 (USD Million)
Table 63 India: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 64 India: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 65 India: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 66 RoAPAC: Market Size, By Type, 2014-2021 (USD Million)
Table 67 RoAPAC: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 68 RoAPAC: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 69 RoAPAC: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)
Table 70 Number of Organ Donations (2008 vs 2015)
Table 71 RoW: Market Size, By Type, 2014-2021 (USD Million)
Table 72 RoW: Cardiopulmonary Perfusion Systems Market Size, By Component, 2014-2021 (USD Million)
Table 73 RoW: Cell Perfusion Systems Market Size, By Type, 2014-2021 (USD Million)
Table 74 RoW: EX Vivo Organ Perfusion Market Size, By Technique, 2014-2021 (USD Million)

List of Figures (61 Figures)

Figure 1 Perfusion Systems Market Segmentation
Figure 2 Perfusion Systems Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design
Figure 8 Data Triangulation Methodology
Figure 9 Perfusion Systems Market, By Type: Cardiopulmonary Perfusion Systems Segment Accounted for the Largest Market Share in 2016
Figure 10 Cardiopulmonary Perfusion Systems Market Size, By Component, 2016 vs 2021
Figure 11 EX Vivo Organ Perfusion Market Size (USD Million), By Technique, 2016 vs 2021
Figure 12 Cell Perfusion Systems Market Size, By Type, 2016 vs 2021
Figure 13 Geographic Snapshot of the Market
Figure 14 North America Accounted for the Largest Share of the Perfusion Systems Market in 2016
Figure 15 Cardiopulmonary Perfusion Segment Dominated the Perfusion Systems Market in 2016
Figure 16 Bioreactor Perfusion Systems Will Continue to Dominate the Cell Perfusion Systems Market in 2021
Figure 17 North America to Register the Highest CAGR During the Forecast Period
Figure 18 Global Market Share, By Region (2016–2021)
Figure 19 North America: Market Snapshot
Figure 20 NIH Spending on Stem Cell Research, 2013-2016 (USD Billion)
Figure 21 Number of New Biotechnology and Pharmaceutical Companies, 2014-2016
Figure 22 Europe: Market Snapshot
Figure 23 APAC: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 Dive Chart
Figure 26 Getinge AB: Company Snapshot (2016)
Figure 27 Getinge AB: Product Offering Scorecard
Figure 28 Getinge AB: Business Strategy Scorecard
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Medtronic PLC: Product Offering Scorecard
Figure 31 Medtronic PLC: Business Strategy Scorecard
Figure 32 Livanova PLC: Company Snapshot (2015)
Figure 33 Livanova PLC: Product Offering Scorecard
Figure 34 Livanova PLC: Business Strategy Scorecard
Figure 35 Terumo Corporation: Company Snapshot (2015)
Figure 36 Terumo Corporation: Product Offering Scorecard
Figure 37 Terumo Corporation: Business Strategy Scorecard
Figure 38 Nipro Corporation: Company Snapshot (2015)
Figure 39 Nipro Corporation: Product Offering Scorecard
Figure 40 Nipro Corporation: Business Strategy Scorecard
Figure 41 Xenios AG: Product Offering Scorecard
Figure 42 Xenios AG: Business Strategy Scorecard
Figure 43 Repligen Corporation: Company Snapshot (2015)
Figure 44 Repligen Corporation: Product Offering Scorecard
Figure 45 Repligen Corporation: Business Strategy Scorecard
Figure 46 Spectrum Laboratories, Inc.: Product Offering Scorecard
Figure 47 Spectrum Laboratories, Inc.: Business Strategy Scorecard
Figure 48 Merck KGaA: Company Snapshot (2015)
Figure 49 Merck KGaA: Product Offering Scorecard
Figure 50 Merck KGaA: Business Strategy Scorecard
Figure 51 Harvard Bioscience, Inc.: Company Snapshot (2015)
Figure 52 Harvard Bioscience, Inc.: Product Offering Scorecard
Figure 53 Harvard Bioscience, Inc.: Business Strategy Scorecard
Figure 54 ALA Scientific Instruments, Inc.: Product Offering Scorecard
Figure 55 ALA Scientific Instruments, Inc.: Business Strategy Scorecard
Figure 56 Lifeline Scientific, Inc.: Company Snapshot (2015)
Figure 57 Lifeline Scientific, Inc.: Product Offering Scorecard
Figure 58 Lifeline Scientific, Inc.: Business Strategy Scorecard
Figure 59 Xvivo Perfusion AB: Company Snapshot (2015)
Figure 60 Xvivo Perfusion AB: Product Offering Scorecard
Figure 61 Xvivo Perfusion AB: Business Strategy Scorecard


【レポート販売概要】

■ タイトル:灌流装置の世界市場予測(~2021年)
■ 英文:Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021
■ 発行日:2017年4月24日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD5190
■ 調査対象地域:グローバル
  • エチルベンゼン(EB)の世界市場予測
    Ethylbenzene (EB) 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Ethylbenzene (EB) market in the all-in-one report issued in a logical and easily accessible format. In addition to the analy …
  • 心臓補助装置:製品分析
    MediPoint: Cardiac Assist Devices - Current and Pipeline Products Summary While heart transplantation remains the gold standard and preferred treatment option for patients with advanced Congestive Heart Failure (CHF), the number of transplant candidates far exceeds the donor pool. This significant limitation has prompted considerable, continued interest in the development of Cardiac Assist Devices …
  • 米国の注射器・注射針市場見通し(~2021)
    United States Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "United States Syringes and Needles Market Outlook to 2021", provides key market data on the United States Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syr …
  • ヘルスケア産業向けIT統合サービスの世界市場
    About healthcare IT integration Businesses worldwide are increasingly depending on advanced technologies and IT integration solutions to enhance efficiency and profitability. IT integration has become a key enabler of business functions with more and more processes being supported by innovative IT applications and solutions. Going forward, this trend is expected to intensify further. The healthcar …
  • ソーラーパワーの技術分析:Analyzing Solar Power Technologies
    The solar PV market has been booming over the last years and is forecasted to confirm this trend in the coming years. The harnessing of solar energy is not new in fact, development of solar energy dates back more than 100 years, to the middle of the industrial revolution. Solar energy is pollution-free, an important benefit when the cost of removing pollutants from the environment is considered. F …
  • リビアの防衛市場動向
    Summary The Future of the Libyan Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2019 published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast Libyan defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news Key …
  • Warts:グローバル臨床試験レビューH1, 2013
    Warts Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Warts Global Clinical Trials Review, H1, 2013" provides data on the Warts clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Warts. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across …
  • 世界の粒度分析(粒子径分析器)市場(2014-2018)
    About Particle Size Analysis Particle size analysis is a technique used to determine the size of a particle in a material such as powder or liquid. It is crucial to analyze the size of particles as it can affect the functionality of the material. Therefore, particle size analysis is performed to determine the behavior and nature of a material, and for its effective functioning (performance and sta …
  • 欧州主要国の心臓人工弁市場見通し(~2021)
    EU5 Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "EU5 Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the EU5 Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Heart Valve ( …
  • 仮想現実(VR)の世界市場予測(~2024年)
    “Virtual reality market projected to grow at 33.47% CAGR during 2018–2024” The virtual reality (VR) market is expected to grow from USD 7.9 billion in 2018 to USD 44.7 billion by 2024, at a CAGR of 33.47% during the forecast period. The penetration of HMDs in the gaming and entertainment sector, huge investments in VR market, advancement of technology and growing digitization, and availability of …
  • 水性耐火塗料の世界市場予測(~2023年)
    “The intumescent coatings market is projected to grow at a CAGR of 4.3% from 2018 to 2023”The intumescent coatings market is expected to grow from an estimated USD 900.1 million in 2018 to USD 1,110.0 million by 2023, at a CAGR of 4.3% from 2018 to 2023. The increasing demand for intumescent coatings across various end-use industries, including building & construction and industrial segments is ex …
  • 世界の自動車用接着剤市場2015
    The Global Automotive Adhesives Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Adhesives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Adhesives market analysis is provided for the international markets including develop …
  • フライアッシュ(セノスフェア)ミクロスフェアの世界市場:種類別(固体、中空粒子)、材料別(フライアッシュ、ガラス、セラミック、金属、高分子)、用途別(石油・ガス、医療技術、塗料・コーティング剤、自動車、建設用複合材料、化粧品・パーソナルケア用品、航空宇宙、ライフサイエンス・バイオテクノロジー)、地域別予測
    Global Fly Ash (Cenospheres) Microspheres Market to reach USD XXX billion by 2025. Global Fly Ash (Cenospheres) Microspheres Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors predicted to augment the markets are increase in end use industry such as construction, ceramics, autom …
  • 末梢T細胞リンパ腫(PTCL):グローバル臨床試験レビュー(2014年上半期)
    Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H1, 2014" provides data on the Peripheral T-Cell Lymphomas (PTCL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral T-Cell Lymphomas (PTCL). …
  • フィリピンの契約物流市場2015-2019
    This market is expected to grow at a steady rate during the forecast period. Its growth is attributed to the high demand for electronic and hardware products in the Philippines market. The contract logistics market in the Philippines by transportation was valued at close to USD 269 million in 2014. The key international player in the contract Logistics market in the Philippines are DHL, FedEx, UPS …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。